Cannabinoid Receptor 1 antibody [C1C2], Internal
|Applications||ICC/IF, IHC, IHC-P, WB|
Not tested in other applications.
| ICC/IF||Assay-dependent dilution
| Immunohistochemistry||Assay-dependent dilution
|IHC (Formalin-fixed paraffin-embedded sections)||1:100-1:1000*
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||53 kDa (note)
|Positive Controls||U87-MG , human CB1-transfected HEK-293T cells (100℃) , mouse brain , Rat2 , *NSC34 |
(Please refer to the vial label for the specific concentration)|
|Purification||Affinity purified by Protein A.|
|Full Name||cannabinoid receptor 1 (brain)|
|Product Description||Rabbit Polyclonal antibody to Cannabinoid Receptor 1 (cannabinoid receptor 1 (brain))|
|Background||This gene encodes a protein that is one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the family of guanine-nucleotide-binding protein (G-protein) coupled receptors which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Two transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq]|
|Synonyms||CANN6 antibody, CB-R antibody, CB1 antibody, CB1A antibody, CB1K5 antibody, CB1R antibody, CNR antibody, CNR1 antibody, central cannabinoid receptor antibody, cannabinoid receptor 1 antibody, cannabinoid receptor 1 (brain) antibody|
|Cellular Localization||Cell membrane |
|Immunogen||Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human Cannabinoid Receptor 1. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse, Rat|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Cat, Rhesus Monkey, Chimpanzee, Bovine|
|Predict Reactivity Note||Cat (100%), Rhesus Monkey (100%), Chimpanzee (100%), Bovine (100%)|